Adams Diversified Equity Fund’s Vertex Pharmaceuticals VRTX Stock Holding History

Adams Diversified Equity Fund’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.5M	Buy	+47,300	New	+$21M	0.72%	32
2025 Q4	–	Sell	-35,100	Closed	-$13.7M	–	104
2025 Q3	$13.7M	Hold	35,100	–	–	0.46%	69
2025 Q2	$15.6M	Hold	35,100	–	–	0.56%	58
2025 Q1	$17M	Hold	35,100	–	–	0.68%	55
2024 Q4	$14.1M	Hold	35,100	–	–	0.53%	67
2024 Q3	$16.3M	Buy	+35,100	New	+$16.9M	0.6%	63
2021 Q2	–	Sell	-71,200	Closed	-$15.3M	–	114
2021 Q1	$15.3M	Hold	71,200	–	–	0.65%	51
2020 Q4	$16.8M	Buy	71,200 +19,100	+37%	+$4.38M	0.76%	43
2020 Q3	$14.2M	Buy	+52,100	New	+$14.4M	0.69%	58

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Adams Diversified Equity Fund's VRTX Position: Q2 2026 in Review

Adams Diversified Equity Fund opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 47,300 shares worth $23.5M. The stake represents 0.72% of the portfolio and ranks #32 among its holdings. This is a return to the name: Adams Diversified Equity Fund previously reported a position in VRTX as recently as Q3 2025.

Adams Diversified Equity Fund first reported a position in VRTX in Q3 2020 and has held it in 9 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Adams Diversified Equity Fund held 47,300 shares of Vertex Pharmaceuticals worth $23.5M as of Q2 2026.
Vertex Pharmaceuticals was a new Adams Diversified Equity Fund position in Q2 2026.
Vertex Pharmaceuticals made up 0.72% of Adams Diversified Equity Fund's portfolio in Q2 2026, its #32 holding.
Adams Diversified Equity Fund first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 9 quarters since.
1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Adams Diversified Equity Fund's 13F filing for Q2 2026, filed 22 Jul 2026.